chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 6.0
Sex: F
Vaccine: FLUC4
Symptoms: Injection site swelling
Clinical narrative: Swelling (hard to the touch), inflammation, redness, pain, and itchiness first emerged around the injection site on the deltoid a few hours after injection. This then spread down arm to the above the elbow over the next 2 days. These symptoms persisted even with administration of benadryl and ibuprofen. Spread has seemed slow and symptoms slightly improved; patient is otherwise stable.
Age: 45.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cardiac stress test, Condition aggravated, Echocardiogram, Electrocardiogram, Electrocardiogram ambulatory
Clinical narrative: Significant increase in frequency of Premature Atrial Contractions within hours of the updated vaccine administration.   Continue 10 days post vaccination.
Age: 45.0
Sex: M
Vaccine: COVID19-2
Symptoms: Supraventricular extrasystoles
Clinical narrative: Significant increase in frequency of Premature Atrial Contractions within hours of the updated vaccine administration.   Continue 10 days post vaccination.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood follicle stimulating hormone increased, Heavy menstrual bleeding, Menopause, Menstruation irregular
Clinical narrative: After I received the vaccine my periods became extremely heavy and irregular. My mom, and grandmothers on both sides didn?t start menopause until after 50.  I went from having my period extremely regular  once a month to every 6 weeks? every few months to now. My last period was 124 days ago in September.
Age: 33.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Injection site swelling, Pain
Clinical narrative: Patient came to the pharmacy stating that 5 days after the imz she had pain and swelling in her right arm. The swelling was around the area where the imz was administered. She showed me her arm and about 2 inches below where she said she received the shot she had a scar from a previous vaccine. The scar was swollen about the size of a walnut. She said her arm was sore to lift. The area where the shot was given was not red. That area did not look swollen. I told the patient to take Tylenol for the pain and use cold compresses. (She stated she is allergic to NSAIDs so she could not take Ibuprofen or Aleve. I also told her to watch the area and if it get worse to see a doctor.
Age: 61.0
Sex: F
Vaccine: PNC20
Symptoms: Chills, Injection site erythema, Injection site pain, Injection site warmth, Night sweats
Clinical narrative: Pt has had worsening redness and pain at injection site since then.  There is redness and mild warmth over L upper arm, pt states this has spread since Tuesday. States pain is sharp, shooting. Worse today. Has also had chills and sweats overnight x 2 nights. Last night required Benadryl to get to sleep due to pain. Is taking Tylenol as well. Also used a topical herb ointment. She has used this ointment before and has never reacted to it.  She was seen 1/12 and treated with keflex and steroid cream in case of celllulitis.
Age: 61.0
Sex: F
Vaccine: PNC20
Symptoms: Pain, Sleep disorder
Clinical narrative: Pt has had worsening redness and pain at injection site since then.  There is redness and mild warmth over L upper arm, pt states this has spread since Tuesday. States pain is sharp, shooting. Worse today. Has also had chills and sweats overnight x 2 nights. Last night required Benadryl to get to sleep due to pain. Is taking Tylenol as well. Also used a topical herb ointment. She has used this ointment before and has never reacted to it.  She was seen 1/12 and treated with keflex and steroid cream in case of celllulitis.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Back pain, Chills, Dyskinesia, Fatigue, Food intolerance
Clinical narrative: After the first dose (received 3/28/2023), I had chills and fever starting about 20 hours after the injection, and neck and back stiffness  and generalized muscle aches for about two days.  I had a migraine and burning pain starting in my upper back and moving to my lower back and buttocks for about two weeks.  After the second dose, symptoms began about 6-8 hours after the injection.  Shivering, fever (up to 102.4, when I last checked it about 9 pm) were worse than with the first dose, and stiffness and pain in my neck and back and upper arms was intense enough that I considered calling to be taken to the hospital.  When I finally was able to fall asleep around midnight, I was wakened suddenly with my head off the pillow and whole body jerking into a ball.  This happened five times, until I finally flattened myself out on my front on the bed. (I had never had seizures or anything like this prior; the jerking seemed like movement I have observed in seizures, but I did not lose consciousness.)  The migrain and body pain lasted more like 4 weeks this time, along with tiredness and intolerance of any caffeine.  The nighttime jerking has continued, but gotten milder and less frequent - from nearly every night at first to just occasionally now.  The most recent time was 1/13/2024.  It is mostly limited now to the legs jerking upwards toward my core, with occasional times with my upper body curling downward.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Insomnia, Musculoskeletal stiffness, Neck pain, Pain, Pain in extremity
Clinical narrative: After the first dose (received 3/28/2023), I had chills and fever starting about 20 hours after the injection, and neck and back stiffness  and generalized muscle aches for about two days.  I had a migraine and burning pain starting in my upper back and moving to my lower back and buttocks for about two weeks.  After the second dose, symptoms began about 6-8 hours after the injection.  Shivering, fever (up to 102.4, when I last checked it about 9 pm) were worse than with the first dose, and stiffness and pain in my neck and back and upper arms was intense enough that I considered calling to be taken to the hospital.  When I finally was able to fall asleep around midnight, I was wakened suddenly with my head off the pillow and whole body jerking into a ball.  This happened five times, until I finally flattened myself out on my front on the bed. (I had never had seizures or anything like this prior; the jerking seemed like movement I have observed in seizures, but I did not lose consciousness.)  The migrain and body pain lasted more like 4 weeks this time, along with tiredness and intolerance of any caffeine.  The nighttime jerking has continued, but gotten milder and less frequent - from nearly every night at first to just occasionally now.  The most recent time was 1/13/2024.  It is mostly limited now to the legs jerking upwards toward my core, with occasional times with my upper body curling downward.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia, Sleep disorder
Clinical narrative: After the first dose (received 3/28/2023), I had chills and fever starting about 20 hours after the injection, and neck and back stiffness  and generalized muscle aches for about two days.  I had a migraine and burning pain starting in my upper back and moving to my lower back and buttocks for about two weeks.  After the second dose, symptoms began about 6-8 hours after the injection.  Shivering, fever (up to 102.4, when I last checked it about 9 pm) were worse than with the first dose, and stiffness and pain in my neck and back and upper arms was intense enough that I considered calling to be taken to the hospital.  When I finally was able to fall asleep around midnight, I was wakened suddenly with my head off the pillow and whole body jerking into a ball.  This happened five times, until I finally flattened myself out on my front on the bed. (I had never had seizures or anything like this prior; the jerking seemed like movement I have observed in seizures, but I did not lose consciousness.)  The migrain and body pain lasted more like 4 weeks this time, along with tiredness and intolerance of any caffeine.  The nighttime jerking has continued, but gotten milder and less frequent - from nearly every night at first to just occasionally now.  The most recent time was 1/13/2024.  It is mostly limited now to the legs jerking upwards toward my core, with occasional times with my upper body curling downward.
Age: 11.0
Sex: M
Vaccine: FLU4, MNQ, TDAP
Symptoms: Peripheral swelling, Skin abrasion, Skin warm
Clinical narrative: The left arm that had MCV40 vaccine had a large, red, swollen, warm to the touch patch. The right arm that had the flu and T-dap vaccines still had a red, swollen, warm to the touch smaller patch.
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Back pain, Fatigue, Gait inability, Mobility decreased, Muscular weakness
Clinical narrative: Had fatigue & leg weakness so bad was unable to walk. soreness severe to left side. radiates around to back. unable to wear anything middle. unable to lift arm. patient had vaccine at Dr office. reported incident to health Dept
Age: 76.0
Sex: F
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: Had fatigue & leg weakness so bad was unable to walk. soreness severe to left side. radiates around to back. unable to wear anything middle. unable to lift arm. patient had vaccine at Dr office. reported incident to health Dept
Sex: U
Vaccine: COVID19, FLUX
Symptoms: Adnexa uteri mass, Altered state of consciousness, Anorectal disorder, Aphasia, Biopsy brain
Clinical narrative: Patient_is a_62 y.o._right handed_female_who presents to the hospital on_12/23/2023_with AMS, aphasia, witnessed convulsive activities. Seizures are focal non motor without impairs awareness with secondary generalization and impaired awareness, likely provoked by COVID and influenza vaccine on 12/22, and/or mild hyponatremia (Na 130). Pt had right painful paresthesia, focal seizures, and aphasia after her Moderna COVID and influenza administered at the same time on 12/22/23.   62-year-old female with past medical hx of HTN, GI obstruction with partial bowel resection as a child and some bladder surgery presents with AMS, a failure, witnessed seizures which are focal, normal motor without impaired awareness and aphasia.   #Neuro: Apahsia with pathologic lesion seen in left temporal lobe on MRI concerning for HSV encephalitis vs. Other viral encephalitis vs. Al encephalitis vs. Malignancy/lymphoma -CT CAP revealed rectal thickening and right pelvic lesion 3.7cm, findings concerning for malignancy -Serum Paraneoplastic panel (pending) CEA, CA125: WNML -Not enough CSF to add on CSF paraneoplastic panel -s/p Brain Biopsy 12/29. Pathology and culture results pending. -1/5/24 Dr. with the path department informed me that the brain biopsy is still inconclusive and pt has "(FS) Hypercellular brain tissue with gllosis and chronic inflammation"  -small post-operative ICH i left temporal lobe noted -No antiplatelets, therapeutic anticoagulation or NSAIDs -Neurology following -CSF WBC 2 (Neutrophils 83), RBC 480, Glucose 54, Protein 21 -ME panel negative -CSF HSV PCR, HHV-6 and VZV: negative -Cont Empiric Acyclovir plan to complete 2 week curse to end on 1/7 -CSF Cytology negative for malignant cells -ID following -CSF Encephalopathy autoimmune pending  -Cont Gabapentin for intermittent episodes of right sided parasthesias  -Follow up final pathology in 1-2 weeks with neurosurgery -PT/OT recommends home with supervision  #Rectal thickening and right pelvic lesion 3.7cm, findings concerning for malignancy #Right adnexel mass -Gl and Oncology Consulted regarding CT scan findings -Flex Sig planned was unrevealing for rectal mass, no biopsy taken -Further evaluation right pelvic lesion pending brain biopsy results -Gynecological oncology follow up outpatient  #Seizure 2/2 to above lesion -video EEG (12/24- 12/26): Left temporal sharps noted -Video EEG (12/28); NO seizures -Cont Keppra 1000mg BID  #Hyponatremia, etiology c/f SIADH -Continue salt tabs , taper to 1g BID -Nephrology following -BMP q48h  #History of Raynaud's reported per patient   Thank you.  Best,  Dr.
Sex: U
Vaccine: COVID19, FLUX
Symptoms: Blood sodium decreased, CSF glucose normal, CSF neutrophil count increased, CSF protein normal, CSF red blood cell count positive
Clinical narrative: Patient_is a_62 y.o._right handed_female_who presents to the hospital on_12/23/2023_with AMS, aphasia, witnessed convulsive activities. Seizures are focal non motor without impairs awareness with secondary generalization and impaired awareness, likely provoked by COVID and influenza vaccine on 12/22, and/or mild hyponatremia (Na 130). Pt had right painful paresthesia, focal seizures, and aphasia after her Moderna COVID and influenza administered at the same time on 12/22/23.   62-year-old female with past medical hx of HTN, GI obstruction with partial bowel resection as a child and some bladder surgery presents with AMS, a failure, witnessed seizures which are focal, normal motor without impaired awareness and aphasia.   #Neuro: Apahsia with pathologic lesion seen in left temporal lobe on MRI concerning for HSV encephalitis vs. Other viral encephalitis vs. Al encephalitis vs. Malignancy/lymphoma -CT CAP revealed rectal thickening and right pelvic lesion 3.7cm, findings concerning for malignancy -Serum Paraneoplastic panel (pending) CEA, CA125: WNML -Not enough CSF to add on CSF paraneoplastic panel -s/p Brain Biopsy 12/29. Pathology and culture results pending. -1/5/24 Dr. with the path department informed me that the brain biopsy is still inconclusive and pt has "(FS) Hypercellular brain tissue with gllosis and chronic inflammation"  -small post-operative ICH i left temporal lobe noted -No antiplatelets, therapeutic anticoagulation or NSAIDs -Neurology following -CSF WBC 2 (Neutrophils 83), RBC 480, Glucose 54, Protein 21 -ME panel negative -CSF HSV PCR, HHV-6 and VZV: negative -Cont Empiric Acyclovir plan to complete 2 week curse to end on 1/7 -CSF Cytology negative for malignant cells -ID following -CSF Encephalopathy autoimmune pending  -Cont Gabapentin for intermittent episodes of right sided parasthesias  -Follow up final pathology in 1-2 weeks with neurosurgery -PT/OT recommends home with supervision  #Rectal thickening and right pelvic lesion 3.7cm, findings concerning for malignancy #Right adnexel mass -Gl and Oncology Consulted regarding CT scan findings -Flex Sig planned was unrevealing for rectal mass, no biopsy taken -Further evaluation right pelvic lesion pending brain biopsy results -Gynecological oncology follow up outpatient  #Seizure 2/2 to above lesion -video EEG (12/24- 12/26): Left temporal sharps noted -Video EEG (12/28); NO seizures -Cont Keppra 1000mg BID  #Hyponatremia, etiology c/f SIADH -Continue salt tabs , taper to 1g BID -Nephrology following -BMP q48h  #History of Raynaud's reported per patient   Thank you.  Best,  Dr.
Sex: U
Vaccine: COVID19, FLUX
Symptoms: CSF white blood cell count negative, Carbohydrate antigen 125 normal, Carcinoembryonic antigen normal, Central nervous system lesion, Computerised tomogram abdomen abnormal
Clinical narrative: Patient_is a_62 y.o._right handed_female_who presents to the hospital on_12/23/2023_with AMS, aphasia, witnessed convulsive activities. Seizures are focal non motor without impairs awareness with secondary generalization and impaired awareness, likely provoked by COVID and influenza vaccine on 12/22, and/or mild hyponatremia (Na 130). Pt had right painful paresthesia, focal seizures, and aphasia after her Moderna COVID and influenza administered at the same time on 12/22/23.   62-year-old female with past medical hx of HTN, GI obstruction with partial bowel resection as a child and some bladder surgery presents with AMS, a failure, witnessed seizures which are focal, normal motor without impaired awareness and aphasia.   #Neuro: Apahsia with pathologic lesion seen in left temporal lobe on MRI concerning for HSV encephalitis vs. Other viral encephalitis vs. Al encephalitis vs. Malignancy/lymphoma -CT CAP revealed rectal thickening and right pelvic lesion 3.7cm, findings concerning for malignancy -Serum Paraneoplastic panel (pending) CEA, CA125: WNML -Not enough CSF to add on CSF paraneoplastic panel -s/p Brain Biopsy 12/29. Pathology and culture results pending. -1/5/24 Dr. with the path department informed me that the brain biopsy is still inconclusive and pt has "(FS) Hypercellular brain tissue with gllosis and chronic inflammation"  -small post-operative ICH i left temporal lobe noted -No antiplatelets, therapeutic anticoagulation or NSAIDs -Neurology following -CSF WBC 2 (Neutrophils 83), RBC 480, Glucose 54, Protein 21 -ME panel negative -CSF HSV PCR, HHV-6 and VZV: negative -Cont Empiric Acyclovir plan to complete 2 week curse to end on 1/7 -CSF Cytology negative for malignant cells -ID following -CSF Encephalopathy autoimmune pending  -Cont Gabapentin for intermittent episodes of right sided parasthesias  -Follow up final pathology in 1-2 weeks with neurosurgery -PT/OT recommends home with supervision  #Rectal thickening and right pelvic lesion 3.7cm, findings concerning for malignancy #Right adnexel mass -Gl and Oncology Consulted regarding CT scan findings -Flex Sig planned was unrevealing for rectal mass, no biopsy taken -Further evaluation right pelvic lesion pending brain biopsy results -Gynecological oncology follow up outpatient  #Seizure 2/2 to above lesion -video EEG (12/24- 12/26): Left temporal sharps noted -Video EEG (12/28); NO seizures -Cont Keppra 1000mg BID  #Hyponatremia, etiology c/f SIADH -Continue salt tabs , taper to 1g BID -Nephrology following -BMP q48h  #History of Raynaud's reported per patient   Thank you.  Best,  Dr.
Sex: U
Vaccine: COVID19, FLUX
Symptoms: Computerised tomogram thorax, Culture, Cytology normal, Electroencephalogram abnormal, Gliosis
Clinical narrative: Patient_is a_62 y.o._right handed_female_who presents to the hospital on_12/23/2023_with AMS, aphasia, witnessed convulsive activities. Seizures are focal non motor without impairs awareness with secondary generalization and impaired awareness, likely provoked by COVID and influenza vaccine on 12/22, and/or mild hyponatremia (Na 130). Pt had right painful paresthesia, focal seizures, and aphasia after her Moderna COVID and influenza administered at the same time on 12/22/23.   62-year-old female with past medical hx of HTN, GI obstruction with partial bowel resection as a child and some bladder surgery presents with AMS, a failure, witnessed seizures which are focal, normal motor without impaired awareness and aphasia.   #Neuro: Apahsia with pathologic lesion seen in left temporal lobe on MRI concerning for HSV encephalitis vs. Other viral encephalitis vs. Al encephalitis vs. Malignancy/lymphoma -CT CAP revealed rectal thickening and right pelvic lesion 3.7cm, findings concerning for malignancy -Serum Paraneoplastic panel (pending) CEA, CA125: WNML -Not enough CSF to add on CSF paraneoplastic panel -s/p Brain Biopsy 12/29. Pathology and culture results pending. -1/5/24 Dr. with the path department informed me that the brain biopsy is still inconclusive and pt has "(FS) Hypercellular brain tissue with gllosis and chronic inflammation"  -small post-operative ICH i left temporal lobe noted -No antiplatelets, therapeutic anticoagulation or NSAIDs -Neurology following -CSF WBC 2 (Neutrophils 83), RBC 480, Glucose 54, Protein 21 -ME panel negative -CSF HSV PCR, HHV-6 and VZV: negative -Cont Empiric Acyclovir plan to complete 2 week curse to end on 1/7 -CSF Cytology negative for malignant cells -ID following -CSF Encephalopathy autoimmune pending  -Cont Gabapentin for intermittent episodes of right sided parasthesias  -Follow up final pathology in 1-2 weeks with neurosurgery -PT/OT recommends home with supervision  #Rectal thickening and right pelvic lesion 3.7cm, findings concerning for malignancy #Right adnexel mass -Gl and Oncology Consulted regarding CT scan findings -Flex Sig planned was unrevealing for rectal mass, no biopsy taken -Further evaluation right pelvic lesion pending brain biopsy results -Gynecological oncology follow up outpatient  #Seizure 2/2 to above lesion -video EEG (12/24- 12/26): Left temporal sharps noted -Video EEG (12/28); NO seizures -Cont Keppra 1000mg BID  #Hyponatremia, etiology c/f SIADH -Continue salt tabs , taper to 1g BID -Nephrology following -BMP q48h  #History of Raynaud's reported per patient   Thank you.  Best,  Dr.
Sex: U
Vaccine: COVID19, FLUX
Symptoms: Herpes simplex test negative, Herpes virus test, Hyponatraemia, Immunisation reaction, Inappropriate antidiuretic hormone secretion
Clinical narrative: Patient_is a_62 y.o._right handed_female_who presents to the hospital on_12/23/2023_with AMS, aphasia, witnessed convulsive activities. Seizures are focal non motor without impairs awareness with secondary generalization and impaired awareness, likely provoked by COVID and influenza vaccine on 12/22, and/or mild hyponatremia (Na 130). Pt had right painful paresthesia, focal seizures, and aphasia after her Moderna COVID and influenza administered at the same time on 12/22/23.   62-year-old female with past medical hx of HTN, GI obstruction with partial bowel resection as a child and some bladder surgery presents with AMS, a failure, witnessed seizures which are focal, normal motor without impaired awareness and aphasia.   #Neuro: Apahsia with pathologic lesion seen in left temporal lobe on MRI concerning for HSV encephalitis vs. Other viral encephalitis vs. Al encephalitis vs. Malignancy/lymphoma -CT CAP revealed rectal thickening and right pelvic lesion 3.7cm, findings concerning for malignancy -Serum Paraneoplastic panel (pending) CEA, CA125: WNML -Not enough CSF to add on CSF paraneoplastic panel -s/p Brain Biopsy 12/29. Pathology and culture results pending. -1/5/24 Dr. with the path department informed me that the brain biopsy is still inconclusive and pt has "(FS) Hypercellular brain tissue with gllosis and chronic inflammation"  -small post-operative ICH i left temporal lobe noted -No antiplatelets, therapeutic anticoagulation or NSAIDs -Neurology following -CSF WBC 2 (Neutrophils 83), RBC 480, Glucose 54, Protein 21 -ME panel negative -CSF HSV PCR, HHV-6 and VZV: negative -Cont Empiric Acyclovir plan to complete 2 week curse to end on 1/7 -CSF Cytology negative for malignant cells -ID following -CSF Encephalopathy autoimmune pending  -Cont Gabapentin for intermittent episodes of right sided parasthesias  -Follow up final pathology in 1-2 weeks with neurosurgery -PT/OT recommends home with supervision  #Rectal thickening and right pelvic lesion 3.7cm, findings concerning for malignancy #Right adnexel mass -Gl and Oncology Consulted regarding CT scan findings -Flex Sig planned was unrevealing for rectal mass, no biopsy taken -Further evaluation right pelvic lesion pending brain biopsy results -Gynecological oncology follow up outpatient  #Seizure 2/2 to above lesion -video EEG (12/24- 12/26): Left temporal sharps noted -Video EEG (12/28); NO seizures -Cont Keppra 1000mg BID  #Hyponatremia, etiology c/f SIADH -Continue salt tabs , taper to 1g BID -Nephrology following -BMP q48h  #History of Raynaud's reported per patient   Thank you.  Best,  Dr.
Sex: U
Vaccine: COVID19, FLUX
Symptoms: Magnetic resonance imaging head abnormal, Mental status changes, Noninfective encephalitis, Pain, Paraesthesia
Clinical narrative: Patient_is a_62 y.o._right handed_female_who presents to the hospital on_12/23/2023_with AMS, aphasia, witnessed convulsive activities. Seizures are focal non motor without impairs awareness with secondary generalization and impaired awareness, likely provoked by COVID and influenza vaccine on 12/22, and/or mild hyponatremia (Na 130). Pt had right painful paresthesia, focal seizures, and aphasia after her Moderna COVID and influenza administered at the same time on 12/22/23.   62-year-old female with past medical hx of HTN, GI obstruction with partial bowel resection as a child and some bladder surgery presents with AMS, a failure, witnessed seizures which are focal, normal motor without impaired awareness and aphasia.   #Neuro: Apahsia with pathologic lesion seen in left temporal lobe on MRI concerning for HSV encephalitis vs. Other viral encephalitis vs. Al encephalitis vs. Malignancy/lymphoma -CT CAP revealed rectal thickening and right pelvic lesion 3.7cm, findings concerning for malignancy -Serum Paraneoplastic panel (pending) CEA, CA125: WNML -Not enough CSF to add on CSF paraneoplastic panel -s/p Brain Biopsy 12/29. Pathology and culture results pending. -1/5/24 Dr. with the path department informed me that the brain biopsy is still inconclusive and pt has "(FS) Hypercellular brain tissue with gllosis and chronic inflammation"  -small post-operative ICH i left temporal lobe noted -No antiplatelets, therapeutic anticoagulation or NSAIDs -Neurology following -CSF WBC 2 (Neutrophils 83), RBC 480, Glucose 54, Protein 21 -ME panel negative -CSF HSV PCR, HHV-6 and VZV: negative -Cont Empiric Acyclovir plan to complete 2 week curse to end on 1/7 -CSF Cytology negative for malignant cells -ID following -CSF Encephalopathy autoimmune pending  -Cont Gabapentin for intermittent episodes of right sided parasthesias  -Follow up final pathology in 1-2 weeks with neurosurgery -PT/OT recommends home with supervision  #Rectal thickening and right pelvic lesion 3.7cm, findings concerning for malignancy #Right adnexel mass -Gl and Oncology Consulted regarding CT scan findings -Flex Sig planned was unrevealing for rectal mass, no biopsy taken -Further evaluation right pelvic lesion pending brain biopsy results -Gynecological oncology follow up outpatient  #Seizure 2/2 to above lesion -video EEG (12/24- 12/26): Left temporal sharps noted -Video EEG (12/28); NO seizures -Cont Keppra 1000mg BID  #Hyponatremia, etiology c/f SIADH -Continue salt tabs , taper to 1g BID -Nephrology following -BMP q48h  #History of Raynaud's reported per patient   Thank you.  Best,  Dr.
Sex: U
Vaccine: COVID19, FLUX
Symptoms: Partial seizures, Pathology test, Pelvic mass, Seizure, Varicella virus test negative
Clinical narrative: Patient_is a_62 y.o._right handed_female_who presents to the hospital on_12/23/2023_with AMS, aphasia, witnessed convulsive activities. Seizures are focal non motor without impairs awareness with secondary generalization and impaired awareness, likely provoked by COVID and influenza vaccine on 12/22, and/or mild hyponatremia (Na 130). Pt had right painful paresthesia, focal seizures, and aphasia after her Moderna COVID and influenza administered at the same time on 12/22/23.   62-year-old female with past medical hx of HTN, GI obstruction with partial bowel resection as a child and some bladder surgery presents with AMS, a failure, witnessed seizures which are focal, normal motor without impaired awareness and aphasia.   #Neuro: Apahsia with pathologic lesion seen in left temporal lobe on MRI concerning for HSV encephalitis vs. Other viral encephalitis vs. Al encephalitis vs. Malignancy/lymphoma -CT CAP revealed rectal thickening and right pelvic lesion 3.7cm, findings concerning for malignancy -Serum Paraneoplastic panel (pending) CEA, CA125: WNML -Not enough CSF to add on CSF paraneoplastic panel -s/p Brain Biopsy 12/29. Pathology and culture results pending. -1/5/24 Dr. with the path department informed me that the brain biopsy is still inconclusive and pt has "(FS) Hypercellular brain tissue with gllosis and chronic inflammation"  -small post-operative ICH i left temporal lobe noted -No antiplatelets, therapeutic anticoagulation or NSAIDs -Neurology following -CSF WBC 2 (Neutrophils 83), RBC 480, Glucose 54, Protein 21 -ME panel negative -CSF HSV PCR, HHV-6 and VZV: negative -Cont Empiric Acyclovir plan to complete 2 week curse to end on 1/7 -CSF Cytology negative for malignant cells -ID following -CSF Encephalopathy autoimmune pending  -Cont Gabapentin for intermittent episodes of right sided parasthesias  -Follow up final pathology in 1-2 weeks with neurosurgery -PT/OT recommends home with supervision  #Rectal thickening and right pelvic lesion 3.7cm, findings concerning for malignancy #Right adnexel mass -Gl and Oncology Consulted regarding CT scan findings -Flex Sig planned was unrevealing for rectal mass, no biopsy taken -Further evaluation right pelvic lesion pending brain biopsy results -Gynecological oncology follow up outpatient  #Seizure 2/2 to above lesion -video EEG (12/24- 12/26): Left temporal sharps noted -Video EEG (12/28); NO seizures -Cont Keppra 1000mg BID  #Hyponatremia, etiology c/f SIADH -Continue salt tabs , taper to 1g BID -Nephrology following -BMP q48h  #History of Raynaud's reported per patient   Thank you.  Best,  Dr.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Chronic lymphocytic leukaemia, Condition aggravated, Leukocytosis, White blood cell count increased
Clinical narrative: Patient had some mild leukocytosis over the past couple of years. Three months after the vaccine her leukocytosis worsened and she was referred to oncology and dx with chronic lymphocytic leukemia
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental overdose, Cough, Headache, Nasal congestion, Oropharyngeal pain
Clinical narrative: Cough; Congestion; Sore throat; Fever; Achy shot site; Was given 0.5 ml when it needed to be 0.25 ml; Bad headache; This spontaneous case was reported by a medical assistant and describes the occurrence of ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml), COUGH (Cough), NASAL CONGESTION (Congestion), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Bad headache) in an 8-year-old female patient who received mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (batch no. AU5558B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Patient had no known allergies to medications, food and other products.  The patient's past medical history included Hyperhidrosis on 27-Feb-2023.    On 25-Oct-2023, the patient received fourth dose of mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use) .5 milliliter. On 25-Oct-2023,  after starting mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024), the patient experienced ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml). On an unknown date, the patient experienced COUGH (Cough), NASAL CONGESTION (Congestion), OROPHARYNGEAL PAIN (Sore throat), HEADACHE (Bad headache), PYREXIA (Fever) and VACCINATION SITE PAIN (Achy shot site). At the time of the report, ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml), COUGH (Cough), NASAL CONGESTION (Congestion), OROPHARYNGEAL PAIN (Sore throat), PYREXIA (Fever) and VACCINATION SITE PAIN (Achy shot site) outcome was unknown and HEADACHE (Bad headache) had resolved.        For mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use), the reporter considered ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml) to have an unknown relationship. No further causality assessments were provided for COUGH (Cough), NASAL CONGESTION (Congestion), OROPHARYNGEAL PAIN (Sore throat), HEADACHE (Bad headache), PYREXIA (Fever) and VACCINATION SITE PAIN (Achy shot site).    Concomitant medications were not reported.  The patient had a bad headache for 2 days.  Treatment information was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-747540 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-747540:master case
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Cough; Congestion; Sore throat; Fever; Achy shot site; Was given 0.5 ml when it needed to be 0.25 ml; Bad headache; This spontaneous case was reported by a medical assistant and describes the occurrence of ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml), COUGH (Cough), NASAL CONGESTION (Congestion), OROPHARYNGEAL PAIN (Sore throat) and HEADACHE (Bad headache) in an 8-year-old female patient who received mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (batch no. AU5558B) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Patient had no known allergies to medications, food and other products.  The patient's past medical history included Hyperhidrosis on 27-Feb-2023.    On 25-Oct-2023, the patient received fourth dose of mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use) .5 milliliter. On 25-Oct-2023,  after starting mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024), the patient experienced ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml). On an unknown date, the patient experienced COUGH (Cough), NASAL CONGESTION (Congestion), OROPHARYNGEAL PAIN (Sore throat), HEADACHE (Bad headache), PYREXIA (Fever) and VACCINATION SITE PAIN (Achy shot site). At the time of the report, ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml), COUGH (Cough), NASAL CONGESTION (Congestion), OROPHARYNGEAL PAIN (Sore throat), PYREXIA (Fever) and VACCINATION SITE PAIN (Achy shot site) outcome was unknown and HEADACHE (Bad headache) had resolved.        For mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use), the reporter considered ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml) to have an unknown relationship. No further causality assessments were provided for COUGH (Cough), NASAL CONGESTION (Congestion), OROPHARYNGEAL PAIN (Sore throat), HEADACHE (Bad headache), PYREXIA (Fever) and VACCINATION SITE PAIN (Achy shot site).    Concomitant medications were not reported.  The patient had a bad headache for 2 days.  Treatment information was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-747540 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-747540:master case
Age: 7.0
Sex: M
Vaccine: COVID19, FLUC3
Symptoms: Overdose, SARS-CoV-2 test, Vaccination site pain
Clinical narrative: Was given 0.5 ml when it needed to be 0.25 ml; no noticeable side effects besides achy shot site; This spontaneous case was reported by a medical assistant and describes the occurrence of VACCINATION SITE PAIN (no noticeable side effects besides achy shot site) and OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml) in a 7-year-old male patient who received mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (batch no. AU5550B) for COVID-19 prophylaxis.    Co-suspect product included non-company product INFLUENZA VACCINE INACT SAG 3V (FLUCELVAX) for an unknown indication.    No Medical History information was reported.   On 25-Oct-2023, the patient received dose of mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use) .5 milliliter. On an unknown date, the patient received dose of INFLUENZA VACCINE INACT SAG 3V (FLUCELVAX) (Intramuscular use) 1 dosage form. In 2023, the patient experienced VACCINATION SITE PAIN (no noticeable side effects besides achy shot site). On 25-Oct-2023,  after starting mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024), the patient experienced OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml). At the time of the report, VACCINATION SITE PAIN (no noticeable side effects besides achy shot site) and OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Dec-2020, SARS-CoV-2 test: (Positive) swab.     For mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use), the reporter considered OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml) to be not related. No further causality assessment was provided for VACCINATION SITE PAIN (no noticeable side effects besides achy shot site).    Concomitant medications were not reported.  No acute illness at the time of vaccination and up to one month before was reported.  No chronic or long-standing health conditions were reported.  It was unknown If patient took any prescriptions, over the counter medications, dietary supplements or herbal remedies being taken at the time of vaccination and/or at the time of adverse event.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-747540 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-747540:Patient 5
Age: 3.0
Sex: F
Vaccine: COVID19, FLUC3, HEPA, PNC15, VARCEL
Symptoms: Accidental overdose, Vaccination site pain
Clinical narrative: Was given 0.5 ml when it needed to be 0.25 ml; after vaccine no noticeable side effects besides achy shot site; This spontaneous case was reported by a medical assistant and describes the occurrence of VACCINATION SITE PAIN (after vaccine no noticeable side effects besides achy shot site) and ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml) in a 3-year-old female patient who received mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (batch no. AU5558B) for COVID-19 prophylaxis.    Co-suspect products included non-company products PNEUMOCOCCAL VACCINE CONJ 15V (CRM197) (VAXNEUVANCE) for an unknown indication, VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK) (VARIVAX [VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK)]) for an unknown indication, HEPATITIS A VACCINE INACT (VAQTA) for an unknown indication and INFLUENZA VACCINE INACT SAG 3V (FLUCELVAX) for an unknown indication.    No Medical History information was reported.   On 26-Oct-2023, the patient received first dose of mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use) .5 milliliter, first dose of PNEUMOCOCCAL VACCINE CONJ 15V (CRM197) (VAXNEUVANCE) (Intramuscular use) 1 dosage form, first dose of VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK) (VARIVAX [VARICELLA ZOSTER VACCINE LIVE (OKA/MERCK)]) (Subcutaneous use) 1 dosage form, first dose of HEPATITIS A VACCINE INACT (VAQTA) (Intramuscular use) 1 dosage form and first dose of INFLUENZA VACCINE INACT SAG 3V (FLUCELVAX) (Intramuscular use) 1 dosage form. In 2023, the patient experienced VACCINATION SITE PAIN (after vaccine no noticeable side effects besides achy shot site). On 26-Oct-2023, the patient experienced ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml). At the time of the report, VACCINATION SITE PAIN (after vaccine no noticeable side effects besides achy shot site) and ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml) outcome was unknown.        The action taken with mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use) was unknown.   For mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use), the reporter considered ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml) to be not related. No further causality assessment was provided for VACCINATION SITE PAIN (after vaccine no noticeable side effects besides achy shot site).    The patient had no allergies to medications, food and other products. The had no acute illness at the time of vaccination and up to one month before and no chronic or long-standing health conditions. The patient did not take any prescriptions, over the counter medications, dietary supplements or herbal remedies at the time of vaccination and/or at the time of adverse event. No treatment medication was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-747540 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-747540:
Age: 2.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental overdose, Vaccination site pain
Clinical narrative: achy shot site; Was given 0.5 ml when they needed 0.25 ml/The vaccination provider felt that the entire contents should be given to a patient as it is a single dose vial; This spontaneous case was reported by a medical assistant and describes the occurrence of VACCINATION SITE PAIN (achy shot site) and ACCIDENTAL OVERDOSE (Was given 0.5 ml when they needed 0.25 ml/The vaccination provider felt that the entire contents should be given to a patient as it is a single dose vial) in a 24-month-old female patient who received mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (batch no. AU5558B) for COVID-19 prophylaxis.    Co-suspect product included non-company product INFLUENZA VACCINE INACT SAG 3V (FLUCELVAX) for an unknown indication.    No Medical History information was reported.   On 26-Oct-2023, the patient received fourth dose of mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use) .5 milliliter and first dose of INFLUENZA VACCINE INACT SAG 3V (FLUCELVAX) (Intramuscular use) 1 dosage form. On 26-Oct-2023, the patient experienced ACCIDENTAL OVERDOSE (Was given 0.5 ml when they needed 0.25 ml/The vaccination provider felt that the entire contents should be given to a patient as it is a single dose vial). On an unknown date, the patient experienced VACCINATION SITE PAIN (achy shot site). At the time of the report, VACCINATION SITE PAIN (achy shot site) and ACCIDENTAL OVERDOSE (Was given 0.5 ml when they needed 0.25 ml/The vaccination provider felt that the entire contents should be given to a patient as it is a single dose vial) outcome was unknown.        For mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use), the reporter considered ACCIDENTAL OVERDOSE (Was given 0.5 ml when they needed 0.25 ml/The vaccination provider felt that the entire contents should be given to a patient as it is a single dose vial) to be not related. No further causality assessment was provided for VACCINATION SITE PAIN (achy shot site).    Patient had no known allergies. It was unknown if patient had diagnosed/tested positive for COVID-19. Patient had no acute or chronic long-standing health conditions at the time of vaccination.  No relevant concomitant medications were reported. No treatment medication reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-747540 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-747540:Master case (Patient 1)
Age: 3.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental overdose, Pyrexia
Clinical narrative: Was given 0.5 ml when it needed to be 0.25 ml; Patient had fever after vaccination; This spontaneous case was reported by a medical assistant and describes the occurrence of PYREXIA (Patient had fever after vaccination) and ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml) in a 3-year-old female patient who received mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (batch no. AU5558B) for COVID-19 prophylaxis.     Concurrent medical conditions included Allergy to antibiotic (Amoxicillin) and Exposure to lead since 27-Jul-2021.    On 24-Oct-2023, the patient received fourth dose of mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use) .5 milliliter. In 2023, the patient experienced PYREXIA (Patient had fever after vaccination). On 24-Oct-2023,  after starting mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024), the patient experienced ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml). At the time of the report, PYREXIA (Patient had fever after vaccination) and ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml) outcome was unknown.        For mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use), the reporter considered ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml) to be not related. No further causality assessment was provided for PYREXIA (Patient had fever after vaccination).    The patient was not taking any prescriptions, over-the-counter medications, dietary supplements, or herbal remedies at the time of vaccination or at the time of adverse event. Patient was never diagnosed with or tested positive for COVID-19. Patient had no chronic or long-standing health conditions. Treatment medication was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-747540 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-747540:Master case (Patient 1)
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
Clinical narrative: COVID 19 treatment; COVID 19 treatment; This is a spontaneous report received from a Consumer or other non HCP.  A 66-year-old male patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 05Nov2023 at 14:00 as dose 1, single (batch/lot number: HG5967) at the age of 66 years, in left arm for covid-19 immunization. The patient's relevant medical history included: "MGUS" (unspecified if ongoing); "migraine" (unspecified if ongoing); "GERD" (unspecified if ongoing); "postnasal drip" (unspecified if ongoing); "sudden hearing loss" (unspecified if ongoing); "lower back pain" (unspecified if ongoing); "chronic bacterial prostatitis" (unspecified if ongoing); "BPH prostatitis" (unspecified if ongoing); "BPH" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (dose 5), for Covid-19 Immunization; Covid-19 vaccine (dose 4), for Covid-19 Immunization; Covid-19 vaccine (dose 3), for Covid-19 Immunization; Covid-19 vaccine (dose 2), for Covid-19 Immunization; Covid-19 vaccine (dose 1), for Covid-19 Immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 treatment". The patient underwent the following laboratory tests and procedures: Covid test: (unspecified date) negative; (07Jan2024) negative, notes: 2nd test 4 days after last dose of Paxlovid; (09Jan2024) positive, notes: tested positive 6 days after last dose of Paxlovid. Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid from 30Dec2023 to 03Jan2024.
Age: 4.0
Sex: F
Vaccine: COVID19, DTAPIPV, MMRV
Symptoms: Accidental overdose, Pyrexia
Clinical narrative: Was given 0.5 ml when it needed to be 0.25 ml; Fever; This spontaneous case was reported by a medical assistant and describes the occurrence of PYREXIA (Fever) and ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml) in a 4-year-old female patient who received mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (batch no. AU5558B) for COVID-19 prophylaxis.    Co-suspect products included non-company products QUADRACEL for an unknown indication and PROQUAD for an unknown indication.    Patient was not allergic to medications, food and other products. Patient had never been diagnosed or tested positive for Covid-19.    On 26-Oct-2023, the patient received fourth dose of mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use) .5 milliliter, fifth dose of QUADRACEL (Intramuscular use) 1 dosage form and second dose of PROQUAD (Subcutaneous use) 1 dosage form. In 2023, the patient experienced PYREXIA (Fever). On 26-Oct-2023, the patient experienced ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml). In 2023, PYREXIA (Fever) had resolved. At the time of the report, ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml) outcome was unknown.        For mRNA-1273.815 (MODERNA COVID-19 VACCINE 2023-2024) (Intramuscular use), the reporter considered PYREXIA (Fever) to be not related and ACCIDENTAL OVERDOSE (Was given 0.5 ml when it needed to be 0.25 ml) to be not applicable.    No Concomitant medications provided by the reporter. Patient fever lasted for two days. At the time of vaccination and up to one month before patient did not have acute illness. Patient did not have any chronic or long-standing health condition. The adverse event fever did not cause patient to seek medical care and there was no other potential cause for this adverse event. Patient did not experience similar event (fever) in the past. No treatment medications provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-747540 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-747540:Master case